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1. Introduction 
A renal abscess is an accumulation of pus inside renal parenchyma. The presence of pus can 
be substantiated by means of imaging or percutaneous aspiration. When we say pus, we 
usually mean liquefaction while there is also another entity we can call a gaseous abscess 
resembling emphysematous pyelonephritis in imaging, but following a more benign course 
such as a localized renal abscess [1]. 
1.1 Pathophysiology 
A host of organisms may cause a renal abscess. There seems to be a chronological shift of 
organisms from  staphylococci to Gram negatives since 25 years ago with prevailing use of 
antibiotics.[2] Currently, the most common organisms are E. coli, Klebsiella pneumoniae, 
Pseudomona aeruginosa and Staphylococcus aureus [3]. Other unusual organisms are likely and 
clinical background should raise the suspicion e.g. Salmonella parathyphi A [4], Salmonella 
typhimurium [5], Nocardia [6], Morganella morganii [7], Streptococcus group B [8], Serratia 
marcescens [9]. In immunocompromised and AIDS patients, other opportunistic organisms 
like Aspergillus fumigatus [10] and Mycobacterium avium complex [11] may also be involved. 
Special clinical scenarios must raise suspicion toward specific organisms. Endophthalmitis 
accompanied by renal abscess has been reported with Klebsiella pneumonia and Serratia 
marcescens [9, 12]. In one case, Salmonella virchow phage type 1 renal abscess was reported  in 
association with pelvis transitional cell carcinoma [13]. Renal abscess may also happen as a 
consequence of infective endocarditis metastasis [14]. 
Predisposing factors are diabetes mellitus, urolithiasis, immunosuppression [15] and 
vesicoureteral reflux [16-19]. Nevertheless, it may happen in previously healthy people [20, 21]. 
1.2 Clinical presentation 
Although fever, nausea and vomiting, abdominal and flank pain are cited as usual clinical 
features [3], yet in some instances the symptoms may be insidious and nonspecific [19, 22]. 
Disguised clinical presentations must not be ignored since renal abscess with infectious 
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metastases to the lung has been mistaken with Wilm's tumor [22]. Acute peritonitis as first 
manifestation of a renal abscess has also been reported.[23]Endophthalmitis associated with 
renal abscess and klebsiella pneumonia[12, 23, 24] and Serratia marcescens [9] was mentioned. 
Renal abscess has also been reported in accompaniment with transitional cell carcinoma [25] 
and renal cell carcinoma [13, 25, 26] in the same kidney so a nonresolving mass must be 
approached with suspicion.  
It looks that renal abscess has a high potential for infectious metastasis reasonably justified 
by high vascularity of the kidney; hence, a whole body physical exam must never be 
underrated. 
1.3 Paraclinic findings 
In a series of pediatric patients, urine culture was positive in 60% and blood culture was 
positive in only 2%.[3]. In another series, less than half of the patients had either an 
abnormal urinalysis or urine culture [17]. Thus, there is a high likelihood of negative urine 
and blood cultures.  Leukocytosis is common [17]and elevated blood urea and creatinine 
have been linked with poorer prognosis [15]. 
Sonography is undoubtedly a very useful and accessible tool for detecting renal pathologies, 
but there are still some doubts on its reliability as the sole diagnostic tool for detecting and 
confirming a renal abscess. It seems wise to use sonography as a screening tool and then 
proceed to CT scan if any mass or nephromegaly is seen. The inclusion of nephromegaly as 
a criterion to perform a computerized tomography seems to increase the sensitivity of 
sonography [3]. Actually, we may see a hypoechoic or anechoic mass or nephromegaly. 
There may also be debris inside the mass moving in the position changes [27]. CT must also 
be performed in those patients with normal sonogram, but discordant clinical behavior (lack 
of response to antibiotics, infectious metastases, papillary necrosis, etc), or if there remains 
any doubt in diagnosis based on sonography. 
CT is the most accurate modality for detecting a renal abscess [27]. An abscess usually 
appears as a well-defined low-density mass. An irregular and thick wall or pseudocapsule 
is better imaged after contrast enhancement [28, 29]. A separately defined entity called 
gaseous abscess can also be effectively diagnosed by CT. On CT, gas-forming renal 
abscesses appear as discrete gas pockets without purulent material within the renal 
parenchyma. The interesting point is that in this entity, despite emphysematous 
pyelonephritis gas persisted to exist in images several months after treatment [1]. In CT, 
gas has a HU number≤ -150 but liquid ±10 HU [27]. Although, Inidium 111 and Gallium 
isotope scans may have a role in diagnosis, but false negative results have been reported 
[30]. These scans may be particularly useful when the location of infectious intra 
abdominal process is still unknown. 
In children with a history of febrile urinary infection, performing a MCUG must not be 
neglected. Not only this helps to detect vesicoureteral reflux, but also reveals many 
unsuspected bladder outlet and urethral pathologies. A DMSA scan 6 to 12 months later can 
show the extent of damage to renal parenchyma [3]. 
1.4 Management 
The treatment of renal abscess has changed from open intervention to percutaneous 
drainage and intravenous antibiotic therapy. In a retrospective but critical analytic study, 
abscesses less than 3cm in diameter responded well to antibiotic therapy, those between 3 
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and 5 cm responded 92% to single percutaneous treatment (using either sonography or CT 
guidance), and in abscesses above 5cm responded to multiple drainages (alternatively a 
temporary indwelling pigtail) and antibiotic treatment.[31]. Percutaneous treatment seems 
as effective as open surgical drainage [31, 32]. The presence of immunocompromised state 
must push us one step forward to a more aggressive approach. The choice of antibiotic in 
cases of percutaneous drainage can best be based on aspirate culture results. In non-drained 
cases, positive urine culture can guide the treatment that an empirical regimen covering 
both Gram-negative enteric bacteria and staphylococci can be used otherwise.  In small 
abscesses which do not respond to antibiotics in a timely manner, a percutaneous drainage 
can be both curative and diagnostic. 
Three to six weeks of parenteral and oral antibiotic may be necessary [3], but the duration of 
antibiotic treatment and time of switching to oral treatment must be based on clinical 
response and sonographic follow up. As previously cited, concomitance with renal 
malignancies have been reported thus lack of adequate response to treatment must raise a 
suspicion.  
2. Perinephric abscess 
2.1 Introduction 
Perinephric abscess refers to accumulation of pus inside Gerota's fascia. There may also be 
gas bubbles especially in diabetics due to glucose fermentation [33] and this should not be 
mistaken with separate entity of emphysematous pyelonephritis. 
The incidence ranges from 1 to 10 cases for every 10,000 hospital admissions. Men and 
women are affected with equal frequency. [33] In a population based cohort retrospective 
study in an eleven-year follow-up period [34] the incidence rates for the diabetics and the 
control subjects were 4.6 and 1.1/10000 person-years, respectively, representing an adjusted 
hazard ratio of 3.81 (95% confidence interval 3·44-4·23). Therefore, diabetes mellitus in an 
immunocompromised setting stands as a major predisposing factor. 
2.2 Pathophysiology 
Most of perinephric abscesses are caused by ascending enteric Gram-negative bacteria.[35]. 
In a study of 26 cases, 67% of cultures yielded enteric Gram-negative bacteria[36], however, 
metastatic staphylococcal infections still happen [33].This entity may also follow the 
chronological shift of causative organism of renal abscess. A host of other unusual bacteria 
have also been reported. Among those, Shigella flexneri [37],  Stenotrophomonas maltophilia 
[38], Nocardia [39] group B streptococcus [40], Candida glabrata [41], Aspergillus fumigates  [42], 
Listeria monocytogenes [43], coagulase-negative Staphylococcus [44], Salmonella [45], Torulopsis 
glabrata [46, 47], Bacteroides fragilis [48] and  Trichomonas vaginalis [49] have been reported to 
cause perinephric abscess in non-transplant patients.  Mycoplasma hominis [50], Streptococcus 
agalactiae [51], Nocardia[52], and Gardnerella vaginalis[53] have been reported to cause 
perinephric abscess in patients with kidney graft. In a review of kidney transplant patients 
with perinephric abscess, staphylococci with a prevalence of 36%, and aerobic Gram-
negative rods with a prevalence of 32% were the most common pathogens. Also of note 
were the presence of anaerobes (28%) and candida albicans (4%) [54]. 
There are also predisposing conditions strongly related with development of perinephric 
abscess. In a study on 23 patients, the predisposing conditions were identified as follows: 
diabetes mellitus in 65.2% , history of nephrolithiasis in 43.47%, and the history of urological 
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surgery in 17.38% [55]. In some older series (1977) diabetes had a smaller  role, and the main 
role was attributed to nephrolithiasis (76%)[36]. 
Some special conditions have been described in accompaniment or as a cause of perinephric 
abscess: urinary extravasation associated with renal colic [56], colon carcinoma [57],renal cell 
carcinoma [58], extracorporeal shockwave lithotripsy [59-61], splenic abscess [62, 63], and 
ruptured retrocecal appendicitis [64, 65]. One must not ignore these conditions in the 
management of a perinephric abscess. 
2.3 Clinical presentation 
It may either present as an insidious disease or an acute process. Ascending infections have 
been described to follow an insidious course, but metastatic staphylococcal abscesses may 
show a dramatic course [33]. Yeast abscesses have been described to follow a chronic course 
with nonspecific symptoms that the usual culprits are Candida and Torulopsis species [66]. A 
patient with perinephric abscess has been presented with just a chronic diarrhea and weight 
loss [67]. Therefore, in most cases a high level of suspicion is necessary to proceed to 
appropriate imaging modalities. Unusual presentations as acute peritonitis [68, 69], acute 
pancreatitis [70], and fulminant hepatic failure [71] have been described too. A 
subcutaneous abscess in the loin may root in a perinephric abscess [72]. Nephrobronchial 
fistula may happen in the context of an unknown perinephric abscess; hence, if a patient 
presents perirenal suppurative process with the chest x-ray findings consistent with pleural 
effusion or pulmonary infiltrates, perinephric abscess have to be considered in differential 
diagnosis along with malignancy [73].  
2.4 Paraclinic findings 
Aspirate cultures are undoubtedly the best guide for antibiotic treatment. Laboratory 
findings have also been correlated with prognosis and outcome. 
In a retrospective study recruiting 23 patients, hemoglobin levels and white blood cells 
counts were associated with the loss of the renal unit,  thrombocytopenia was linked with 
septic shock, and hyponatremia with mortality [55]. 
In this study, a hemoglobin concentration greater than 10.5 g/dl and  a white blood cell 
count lower than 15 x 10(3) / microL were associated with nephrectomy, and a platelet 
count lower than 140 x 10(3) / microL with septic shock. General mortality was 8.69%, and 
78.3% of patients required nephrectomy. Patients who died had fever, anemia, a white blood 
cell count greater than 16 x 10(3) / microL, platelet count lower than 130 x 10(3) / microL, 
and hyponatremia of 125 mEq/L or lower at hospital admittance, and all of them had septic 
shock that required nephrectomy. 
Sonography alone may have a substantial risk of incorrect or missed diagnosis. In a study, 
perinephric abscesses which were not seen in ultrasonography were those associated with 
pyonephrosis, abscesses smaller than 6 cm and gas-forming abscesses [74]. Although 
sonography has an important role as a non-ionizing accessible tool of first investigation, it 
could be misleading in some cases. One should not hesitate performing a CT scan in cases of 
urinary tract infection with an unusual course or resistant to antibiotic treatment with normal 
sonography. In another study, sonography failed to show abscesses smaller than 2-3 Cm. 
CT scan has also the advantage of detecting concomitant pathologies cited before. As 
nephrolithiasis has been cited as a major predisposer, the investigation must be completed 
both with and without contrast for optimal results. Gallium-67 scintigraphy appears to be 
useful in detecting perinephric abscess in patients with polycystic kidney disease 
undergoing chronic hemodialysis [75]. 
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2.5 Management 
Antibiotic treatment must be guided by urine, blood or aspirate culture. Before the culture 
results get ready, a regimen covering both Gram-negative enteric bacteria and staphylococci 
is usually adopted. However, the mainstay of treating a perinephric abscess is drainage [33]. 
A percutaneous approach is preferred in most cases unless in multilocular, very large 
abscesses with extremely viscous purulent material in which open drainage is necessary. 
Laparoscopic treatment has been reported [76], but  evidently it has not been introduced as a 
standard method yet. 
Controlling diabetes mellitus or any underlying condition is mandatory. A urinary 
obstruction must be dealt with by either a percutaneous stent, or double J stent, or open 
intervention.  In blood dyscrasias recombinant human granulocyte colony-stimulating factor 
may be helpful [77]. Unusual causative or accompanying conditions cited before must be 
cautiously addressed. Hematuria is uncommon in cases of perinephric abscess. When 
hematuria is present in a patient with perinephric abscess further evaluation is necessary to 
rule out an associated malignant process [58]. 
3. Spectrum of infected hydronephrosis and pyonephrosis 
3.1 Introduction 
Infected hydronephrosis denotes bacterial infection in a hydronephrotic kidney. 
Pyonephrosis occurs when suppurative destruction of parenchyma has begun. By 
definition, both conditions occur in obstructed kidneys. The level of obstruction varies from 
a calyceal infundibulum (pyocalyx) to bladder outlet (pyocystitis/pyonephrosis). 
3.2 Pathophysiology 
The same organisms responsible for acute pyelonephritis may infect a hydronephrotic kidney 
and ultimately lead to pyonephrosis. Staphylococcus aureus, Mycobacterium tuberculosis, Candida 
albicans and Anaerobes are other putative organisms [78-80]. The etiology of obstruction may 
also vary and must be differentiated on the context of patient's age and medical history. One 
must consider that in many cases there may be a disparity between voided urine culture and 
pelvis urine culture aspirated by needle or nephrostomy; hence, the best antibiotic regimen 
must cover both organisms after the aspirate from pelvis is obtained [81]. 
3.3 Clinical presentation 
A patient with these conditions have usually fever and chills, loin pain(in almost all), CVA 
tenderness, lower urinary tract symptoms(48%), and palpable renal mass (58%)[82]. In a 
study, an initial body temperature of above 38.5 degrees Celsius (P=0.0004) and an elevated 
BMI (P=0.002) were connotative as predictors of urosepsis. [83] However, occasionally the 
symptoms may be vague or even totally absent [84].The author draws your attention to a 
case of pyocalyx which may only have a lost calyx in EXU without clinical symptoms of 
infection where an inappropriate ESWL to treat a stone may cause sepsis and eventual death 
(unpublished data). 
3.4 Paraclinic findings 
As previously stated, blood culture, voided urine, and pelvis aspirate guides the antibiotic 
treatment. CRP and ESR were used to differentiate between the infected hydronephrosis 
and pyonephrosis with a cut-off at 3mg/dl for CRP and 100 mm/hr for ESR as useful 
adjuncts for sonographic studies [85]. Cr and blood biochemistry leads to treatment in cases 
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of bilateral obstruction or functional solitary kidneys. The role and presence of predisposers 
like diabetes or immunocompromised states not formerly known must not be overlooked 
and should be evaluated with appropriate investigations. 
In patients with clinical suspicion of renal infection, sonography has an accuracy of up to 
96%.[86]. Sonography can distinguish internal echoes inside the pelvicalyceal system or 
areas of decreased echogenicity inside parenchyma. As previously said, combining 
sonography findings with CRP and ESR may further increase the accuracy of differentiating 
between infected hydronephrosis and pyonephrosis. 
MRI with diffusion-weighted images (MRI Dw) and Apparent Diffusion Coefficient (ADC) 
are helpful to distinguish between infected hydronephrosis and pyonephrosis[87].The 
extremely low ADC of the renal pelvis of the pyonephrotic kidney accounts for its signal 
hyperintensity on diffusion-weighted images as well as signal hypointensity on ADC maps. 
However, the decision to use MRI must be based on the fact that whether or not it could 
change the treatment strategy. Other modalities may be used to discover the etiology of 
obstruction e.g. a spiral non-contrast CT may be the best tool to detect an obstructive 
ureteral stone. 
One must avoid using a retrograde pyelography as it increases the internal pressure of an 
obstructed infected system and may cause urosepsis. Therefore, t should only be done 
after the infection has been eradicated. In addition to relieving the obstruction in the acute 
phase, percutaneous nephrostomy provides the opportunity of antegrade pyelography 
afterwards. Hence, one can have a near physiologic dynamic image while maintaining a 
safety valve. 
3.5 Management 
Starting antibiotic treatment and relieving obstruction in an obstructed infected kidney are 
urgent. One starts antibiotic empirically covering Gram-negatives, anaerobes, and 
staphylococci, and then tailors the regimen according to the aspirate culture. Percutaneous 
nephrostomy has proved to be an ideal option for obstruction relief in multiple case series 
including a prospective study while gaining a reliable culture and providing access for 
subsequent imaging[88-91]. A considerable disparity has been found between the results of 
the pelvis aspirate and the voided urine culture.[81]Nevertheless, the choice of the method 
for relieving obstruction must be astutely individualized. In a pelvic kidney with overlying 
bowel, percutaneous nephrostomy is no longer the ideal first line option and a retrograde 
stent may be preferred if proved feasible. In a child with duplex system and upper moiety 
pyonephrosis, upper moiety cutaneous pyelostomy may be performed. For an irreversibly 
non-functional kidney with a thin parenchyme, a primary nephrectomy may be curative. In 
many cases, a strict differentiation between infected hydronephrosis and pyonephrosis does 
not seem to radically change the treatment strategy. 
4. Acute focal bacterial nephritis (AFBN) or lobar nephronia 
4.1 Introduction 
Acute focal bacterial nephritis (AFBN) or acute lobar nephronia represents as an acute 
localized non-liquefactive infection of the kidney caused by bacterial infection [92]. This 
stipulates that the mass should not contain drainable pus. Actually, it is a precursor step to a 
frank renal abscess before liquefaction. In a study by Klar et al. (1993), of 210 pediatric 
patients admitted to hospital with manifestations of urinary tract infection, 13 had AFBN. 
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Evolution to renal abscess happened in 25%, but all responded well to antibiotic therapy 
[93]. However, it looks that incidence rate may vary according to the ease of access to 
medical facilities and cultural background that may alter the interval between the 
commencement of manifestations of the acute pyelonephritis and the time that antibiotic 
therapy is instituted. 
4.2 Pathophysiology 
The same process that causes acute pyelonephritis may evolve into AFBN and eventually 
abscess. In children, both hematogenous [94] and ascending routes [16] have been 
suspected. Congenital urologic abnormalities especially vesicoureteral reflux has been 
linked with AFBN. Unusual and fastidious organisms e.g. brucellosis especially in endemic 
areas must be kept in mind [95]. Diabetes mellitus is a major predisposing factor in all 
complicated urinary tract infections [96]. 
4.3 Clinical presentation 
Clinical manifestations are similar to acute pyelonephritis, but probably in a more severe 
and durable form. Fever, chills and costovertebral angle tenderness along with signs and 
symptoms of SIRS(Systemic Inflammatory Response Syndrome) could happen [92]. 
However, atypical and imitating clinical pictures may happen as nephrectomy with a 
misdiagnosis of renal tumoral mass has been reported;  hence, the condition has also been 
referred to as renal inflammatory pseudotumor [97]. 
4.4 Paraclinic findings 
One expects an active urinalysis and a positive urine culture in many cases, but the point is 
that in some patients these laboratory findings are absent and a high level of suspicion must 
be put on such cases [94, 98]. 
The value of sonography in diagnosis of AFBN has been somewhat controversial. Some 
consider an average accuracy [99] or even low accuracy [100] in sonography that fails to 
show half and even over the half of the cases. Another study attributes a high accuracy for 
sonographic findings of nephromegaly and focal mass in a pediatric group of patients with 
a specificity of 86% and a sensitivity of up to 95%.[101]. The author thinks one must also 
consider the chronological evolution of sonographic technology between 1988[99], 1989[100] 
and 2004([101]. Newer sonographic apparatus may well be relied upon in revealing renal 
pathologies.  
Reported sonographic appearances of AFBN are varied, but are typically described as being 
echopoor [102], yet at least in one study in 17 patients, the abnormal areas were echogenic in 
12 of them, echopoor in three, and of mixed echogenicity in two [102]. In sonographic 
follow-up, the inflammatory mass may diminish and disappear in 4 weeks. [92]. 
The most valuable modality for detection of AFBN is computerized tomography [103] 
used as reference standard to assess other modalities [29]. AFBN in CT is typically 
hypodense [99] and may help to differentiate them with renal tumors that are most 
commonly hyperdense. Different patterns could be seen in CT that they have been linked 
with prognosis and severity of the disease.  In a retrospective study, the CT appearance of 
AFBN was categorized into three groups: Group I: wedge-shaped lesions (focal or 
diffuse); Group II: focal mass-like lesions; and Group III: diffuse (multifocal) mass-like 
lesions. 
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The clinical features in Group I patients displayed many similarities with those in 
uncomplicated acute pyelonephritis (APN) responding to antibiotic therapy promptly.  
Patients in Group II were successfully treated with antibiotics, but had a protracted clinical 
course with a slower clinical improvement than Group I. Evolution to renal abscess 
happened, though uncommonly. In comparison, 33% of the patients in Group III died 
despite antibiotic therapy[104]. 
We must not neglect to detect associated anomalies of urinary tract especially vesicoureteral 
reflux. In children, doing a MCUG is mandatory. In adults, decision to perform a MCUG 
must be made on the basis of whether VUR can do any further harm or the need for 
additional intervention. 
4.5 Management 
The mainstay of treatment in AFBN is antibiotics. There is a well-designed RCT to 
determine the best duration of treatment [105]. In this study, a three-week antibiotic course 
was clearly superior to a two-week course.  The treatment began with parenteral form, and 
then, switched to oral form 2 to 3 days after defervescence. Antibiotic must be directed 
against Gram-negative organisms  and staphylococci while the culture results are not ready, 
or in the cases that urine and blood cultures are negative and clinical suspicion is high [94]. 
As previously stated, patients with diffuse mass-like lesions on CT may have a grave 
prognosis as 30% of them may die of the disease [104]. Therefore, one could infer that in 
such cases a more vigorous approach including surgery has to be considered. 
5. Chronic pyelonephritis  
5.1 Introduction 
Chronic pyelonephritis is the result  of an underlying renal or urinary tract disease with the 
subsequent repeated renal infection that ends in scarring, atrophy of the kidney, and 
eventual renal insufficiency [106]. Besides the history of UTIs, complicating defects such as 
major anatomic anomalies, urinary tract obstruction, nephrolithiasis, renal dysplasia, 
analgesic abuse , or most commonly, vesicoureteral reflux (VUR) in young children could be 
detected in patients with end-stage renal disease and chronic pyelonephritis.  Nonetheless, it 
has never been found that renal insufficiency has been caused by non-obstructive 
uncomplicated UTI alone [107, 108]. 
There is a gender susceptibility in chronic pyelonephritis as it is twice more common in 
females than in males; there is also a higher occurrence in infants and young children 
(younger than 2 years old) than in older children and adults. Although the greatest risk of 
renal scarring has been reported in young children, additional renal scars could be the result 
of repeated infections. [109] There is a three-time  higher possibility of VUR and chronic 
pyelonephritis in white children than in African-American children [110]. VUR could be 
accompanied by UTIs in 30-45% of children. Moreover, in siblings of patients with chronic 
pyelonephritis, VUR prevalence rate could reach up to around 35% [111, 112]. 
Chronic renal infection can worsen renal impairment significantly in patients with 
underlying functional or structural urinary tract abnormalities; hence, diagnosis, 
localization, and treatment of chronic renal infection are crucial to be found by appropriate 
studies. The diagnosis is made by radiologic or pathologic examination rather than mere 
clinical presentation. 
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In women and in contrary to a 2% to 5% prevalence of bacteriuria, pyelonephritis without 
complications by obstruction or urinary tract malformation does not result in end-stage 
renal disease [111]. 
5.2 Pathology 
In chronic pyelonephritis, the affected kidney in gross is often diffusely shrunk, scarred, and 
pitted. The scars could be described as Y-shaped, flat, broad-based depressions with red-
brown granular bases. Usually, there is a polar scarring with underlying calyceal distortion 
and blunting with thin parenchyma that the cortico-medullary demarcation is lost [113].  
There are microscopic changes that are usually patchy together with an interstitial infiltrate 
of lymphocytes, plasma cells, and occasional polymorphonuclear cells. Some portions of the 
parenchyma are probably replaced by fibrosis and although glomeruli may be preserved, 
periglomerular fibrosis is commonly observed. In parts of the involved areas, glomeruli 
could be completely fibrosed along with atrophied tubules. At times, leukocytes and hyaline 
casts are present in the tubules that the latter may resemble the thyroid colloid where the 
description renal thyroidization is originated [114]. On the whole, the changes are 
nonspecific that could be seen in toxic exposures, post-obstructive atrophy, hematologic 
disorders, post irradiation nephritis, ischemic renal disease, and nephrosclerosis too [113]. 
5.3 Clinical presentation 
Chronic pyelonephritis is usually asymptomatic in many individuals until it produces renal 
insufficiency and then the symptoms are similar to those of any other form of chronic renal 
failure, but they may have a history of frequent UTIs. A strong correlation between renal 
scarring and recurrent UTIs exists in children [115]. Although the developing kidney 
appears to be very susceptible to damage, and this susceptibility appears to be age 
dependent, in adult kidneys, renal scarring induced by UTIs is rare. 
If it is believed that a patient's chronic pyelonephritis is an end result of many episodes of 
acute pyelonephritis, a history of intermittent symptoms of fever, lethargy, flank pain, and 
dysuria could be extracted. Moreover, there is a poor correlation between urinary findings 
and the presence of renal infection. Bacteriuria and pyuria as the hallmarks of UTI, are not 
predictive of renal infection since patients with significant renal infection may have sterile 
urine if the infection is outside of the collecting system or in case of an obstructed ureter 
draining the kidney [107]. 
Chronic pyelonephritis often progress asymptomatically and the diagnosis is usually 
incidental during the radiologic investigation to evaluate for the complications associated 
with renal insufficiency, such as hypertension, visual impairments, headaches, fatigue, and 
polyuria. 
Leukocytes or proteinuria may be detected in urinalysis in these patients, but it is likely to 
be normal. The severity of renal impairment could be reflected by serum creatinine levels. If 
there is an active infection, urine cultures might be positive. 
Differential diagnosis for chronic pyelonephritis includes chronic renal failure, 
hypertension, nephrolithiasis, pyonephrosis, perinephric abscess, acute pyelonephritis, 
uremia, tuberculosis, and some tumor-like lesions in the kidney, namely, 
xanthogranulomatous pyelonephritis, malacoplakia, and lymphoma [116]. 
Chronic pyelonephritis might cause morbidity and mortality by causing following 
conditions:(1) focal glomerulosclerosis, (2) proteinuria, (3) progressive renal scarring, (4) 
hypertension, (5) end-stage renal disease and (6) xanthogranulomatous pyelonephritis 
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(XPN) [112]. The rate of XPN occurrence is 8.2% in such patients and it reaches up to 25% in 
patients with pyonephrosis [117].  
5.4 Paraclinic findings 
Asymmetry and irregularity of the kidney outlines or a small and atrophic kidney on the 
affected side could be easily detected in intravenous pyelogram or CT scan. The 
characteristic signs include focal coarse renal scarring, atrophy and cortical thinning, 
hypertrophy of residual normal tissue (which may mimic a mass lesion) with blunting and 
dilation (clubbing) of one or more underlying calyces [118, 119]. 
In children with gross reflux, voiding cystourethrogram (VCUG) findings may reveal urine 
reflux into the renal pelvis and ureteral dilatation [112].  
Ultrasonography could be used as an alternative that it similarly demonstrates these 
findings. The best imaging modality to look for renal scarring is DMSA [120]. By providing 
high-resolution images of the renal cortex, it allows for both qualitative and quantitative 
characterization of renal injury and impairment. Areas of scarring can be seen as photopenic 
areas usually at poles [120, 121]. 
Once the radiologic changes of chronic pyelonephritis have been established, it is important 
to consider that the repeat of imaging is unlikely to come up with further findings[121]. 
5.5 Management 
Since the damage caused by chronic pyelonephritis is irreversible, the management of the 
radiographic evidence of pyelonephritis should be focused on treating the existing infection, 
preventing future infections, and monitoring and preserving renal function.  
Restricting dietary protein intake can decrease progressive renal injury. The course of renal 
failure progression could be decelerated through regular checking of blood pressure and 
aggressive blood pressure control. ACE inhibitors are considered to be particularly 
beneficial in this setting.  
Careful antimicrobial susceptibility tests and the selection of the non-nephrotoxic drugs that 
yield high urine concentrations must be the basis for the treatment of existing infection. 
Since there is a possible reduction in renal concentrating ability in pyelonephritis, it may 
impair excretion and concentration of the antimicrobial drug needed to achieve acceptable 
bactericidal levels in urine. In order to boost the chance of cure and to avoid recurrence, 
further progression, and renal damage, the duration of the antimicrobial therapy is 
recommended to be prolonged along with continuous prophylactic antibiotic regimes [122].  
There is either an underlying renal (papillary) lesion or a urologic condition such as 
obstruction or calculus available that increases the susceptibility to the renal damage, thus 
appropriate nephrologic and urologic evaluation, treatment and prevention should be 
undertaken to identify and possibly correct these abnormalities. 
Nephrectomy could become necessary in case of hypertension or pain for having a large 
stone burden in a nonfunctioning kidney. 
6. Emphysematous pyelonephritis 
6.1 Introduction 
Emphysematous pyelonephritis (EPN) is defined as a rare, yet an acute severe necrotizing 
infection that involves renal parenchyma and its surrounding tissues causing the presence 
of gas in the renal parenchyma, collecting system or perinephric tissue [123, 124]. 
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Kelly and MacCullum reported the first case of disease in 1898 [125], and then, Schultz and 
Klorfein introduced the term emphysematous pyelonephritis in 1962 [126]. 
It is considered as a rare disease as only 600 cases have been reported from 1966 to date 
[127]. According to some authors EPN is suggested when gas is detected within the renal 
parenchyma or perinephric space, yet it has been defined by several others as gas within the 
collecting system, parenchyma, perirenal space, or in any of these areas [128]. 
Gas could be found not only in the site of inflammation in the sub-capsular, perinephric, 
and pararenal spaces that in some cases, but gas was also detected even in the scrotal sac 
and spermatic cord [129]. 
Emphysematous pyelitis is a separate condition and refers to the presence of gas in the 
collecting systems only and could be secondary to instrumentation of the urinary tract. With 
proper medical management emphysematous pyelitis has an excellent prognosis; however, 
EPN requires special attention due to its life-threatening nature either with medical or 
surgical management. 
Gas could be found in other conditions such as urinary endoscopic procedures, 
genitourinary trauma, communicating fistulas with the gastrointestinal tract, and produced 
by bacteria within the urinary tract [123]. 
The most common associated factor in EPN is diabetes mellitus that an uncontrolled DM is 
present in 95% of the cases [131] and the next common cause is urinary tract obstruction 
[127, 130] that urinary calculi are usually found to be the cause of obstruction [128]. 
A glucose-fermenting bacterial infection, impaired host immunity, decreased tissue 
perfusion, neurogenic bladder, alcoholism, drug abuse, urinary tract obstruction in non-
diabetics  and anatomic anomaly are considered to be the other reported risk factors in EPN 
[123, 130, 131]. 
With the female to male ratio of 4:1 in most studies, it is clear there is a greater tendency of 
the disease toward women  [127, 131] that the reason for the higher incidence in females 
seems to originate from increased susceptibility to UTI. A urinary tract obstruction raises the 
risk of developing secondary EPN to as high as 25–40% [123]. Despite its worldwide spread, 
it seems to be geographically more common in Asia [127]. 
6.2 Pathogenesis 
The mechanism of gas production is the fermentation of the glucose and lactate to carbon 
dioxide causing necrotizing infection in an appropriate tissue environment and it usually 
occurs in the presence of the organisms such as E. coli, Klebsiella spp., Proteus spp., gram-
negative facultative anaerobic organisms. E. coli is found to be the causative agent in almost 70% 
of the reported cases isolated in urine or pus cultures [132]. There is a presence of bacteriemia 
in over 50% of the patients with the same organisms as those in urine or pus culture [130].  
In addition to the aforesaid organisms, Proteus mirabilis, Klebsiella pneumonia, Group D 
Streptococcus, coagulase-negative Staphylococcus, and Candida albicans have been reported as 
the causative agent for EPN too [132].  
In pathology, abscess formation, foci of micro- and macro-infarctions, vascular thrombosis, 
numerous gas-filled spaces and areas of necrosis surrounded by acute and chronic 
inflammatory cells implying septic infarction could be identified in kidney [130, 133]. 
6.3 Clinical presentation 
Most patients are in their forties and fifties [127, 133-135]. The symptoms and signs are 
similar to pyelonephritis and include dysuria, fever, rigorous nausea, vomiting, and flank 
pain [127,129, 132]. 
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The other clinical manifestations to be potentially considered are acute renal dysfunction, 
acid-base disturbances on blood gases, hyperglycemia, thrombocytopenia and impaired 
consciousness [129,130, 135].  There may be a rapid progress into septic shock that could 
even be the presenting feature in patients with severe emphysematous pyelonephritis [130, 
132]. Of the most common physical signs, loin tenderness and in some cases crepitus around 
the renal area and the scrotum may also be felt [129,130, 132]. In laboratory tests, 
leucocytosis could be found in 70–80% of the cases that thrombocytopenia was seen in 15–
20% of the patients [129, 135]. Since most patients suffer from diabetes mellitus, high blood 
glucose level is a common finding. 
Among other positive findings in EPN, acute renal failure, microscopic or macroscopic 
hematuria, and severe proteinuria could be counted too [130].  
In EPN prognosis, many identified factors affect mortality including a systolic blood 
pressure of less than 90 mmHg, disturbance of consciousness and an increase in serum 
creatinine level, thrombocytopenia (OR 22.68, 95% CI 4.4– 16.32) and bilateral EPN (OR 5.36, 
95% CI 1.41 – 20.33) that both are attributable to dire prognosis. Antibiotic therapy alone has 
been associated with a higher risk of mortality (OR 2.85, 95% CI 1.19– 6.81) and it is in 
comparison to the additional interventions of percutaneous drainage (PCD) of the abscess or 
nephrectomy [127, 131]. Based on Wan et al. ’s classification, EPN Type I, as seen below, has 
a ominous prognosis and it is due to the fact that a more fulminating clinical course and 
more extensive parenchymal damage exist [133]. 
Reportedly, although diabetes mellitus is a common risk factor for EPN, but surprisingly it 
does not culminate in an increased mortality [odds ratio (OR) 0.32, 95% CI 0.05–1.99] [133, 
136]. There are also no increased risk of higher mortality in EPN with nephrolithiasis, 
etiologic factors such as E. coli or K. pneumonia [137, 138], age 50 years, female sex, history of 
UTIs, alcoholism, bacteremia, proteinuria (presence of urine protein greater than 3 gm/l on 
at least 2 occasions during admission), retinopathy, and macrohematuria (presence of urine 
red blood cells of over than 100 per high power field) [131]. 
6.4 Paraclinic findings 
As the clinical and the laboratory findings will only point to sepsis of renal origin, 
emphysematous pyelonephritis is a radiological diagnosis mostly. 
In support of the diagnosis, a plain radiograph is indicative of an abnormal gas shadow in 
the renal bed that an ultrasonography or CT will confirm the presence of intra renal gas to 
diagnose EPN. CT is considered to have the highest accuracy of 100%,  hence, it is proven to 
be the most reliable diagnostic tool in EP diagnosis [129]. By identifying parenchymal 
destruction characteristics, it demonstrates the extent of EPN too [130,133, 135]. Since 
ultrasound diagnosis is very much dependent on the operator, it is not sufficiently specific 
when gas-containing lesions are to be characterized. Calculi or bowel gas are the origin of 
mistakes as gas appears as echogenic foci. 
The accuracy of ultrasonography and plain radiograph of the abdomen is around 69 and 
65%, respectively, and it necessitates exploiting abdominal CT for the sake of early diagnosis 
and further management of EPN [127]. 
By analysis based on CT findings, EPN has been classified into two types by Wan et al. in 
1996. [127, 133] According to this classification in type I, there is a renal necrosis with either 
total absence of fluid content or the presence of a streaky/mottled gas pattern whereas there 
is a presence of renal or perirenal fluid along with a loculated gas pattern or the presence of 
gas in the collecting system in type II (Figure 1). Owing to more extensive parenchymal 
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necrosis and more fulminating clinical course, type I EPN is associated with worse 
prognosis [133]. 
 
 
Fig. 1. CT scan showing a large collection with air-fluid level in left retroperitoneal 
cavity.(transverse and coronal view). ( Courtesy of Simforoosh N., Sharifiaghdas F., Parvin 
M.,et al. The book “Urology Cases in Practice”. Labbafinejad Medical Center, Tehran, Iran.) 
In a publication in 2000, Huang and Tseng introduced a new classification based on the CT 
findings described in more details and with more subcategories that was different to the one 
mentioned above [130]. Their classification can be summed up as: (1) Class1: the presence of 
gas in the collecting system only; (2) Class 2: the presence of gas in the renal parenchyma 
without extension to extrarenal space; (3) Class 3A: extension of gas or abscess to 
perinephric space; Class 3B: extension of gas or abscess to pararenal space; and (4) Class 4: 
bilateral EPN or solitary kidney with EPN.  
The purpose of such detailed classification by Huang and Tseng was to show the correlation 
between the EPN classification and its management. 
Nonetheless, the described classification by Wan et al. has been evaluated for the risk factors 
and the management of EPN in two published meta-analyses. 
6.5 Management 
In those patients under the treatment for pyelonephritis, the radiological diagnosis of 
Emphysematous Pyelonephritis could be overlooked unless appropriate imaging is taken. 
In order to confirm the diagnosis in this group of patients, also in individuals with failure in 
responding to the standard line of therapy for pyelonephritis, an urgent CT scan should be 
taken.[134] 
The preliminary treatment is a medical management(MM) by providing basic resuscitation 
measures of oxygen, intravenous fluids, acid base balance correction and proper antibiotics 
along with good glycemic control. It is also necessary to sustain systolic blood pressure at 
above 100 mmHg through fluid resuscitation or inotropic support if a need arises.  
In case of observing deterioration in the clinical condition and the laboratory results, these 
patients should be looked after more vigorously as multi-organ support is possibly 
required. 
The initial antibiotic therapy should be aimed at eliminating Gram-negative bacteria as the 
most common causative organisms. To fulfill this, Aminogycosides, α-lactamase inhibitors, 
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cephalosporins and quinolones could be administered guided by the local hospital policy. 
For the initial stage of treatment, a combination of aminoglycoside with any of the other 
three groups can be used. The choice of antibiotics could be changed for the type and 
number of organisms along with their individual sensitivities accordingly once the culture 
report is ready.  
Emergency nephrectomy and/or open surgical drainage along with antibiotic therapy was 
the accepted treatment of EPN until the late 1980s that had a mortality rate of up to 40–50% 
[123, 139].  
As introduced by Hudson et al., fluoroscopy guided percutaneous drainage (PCD) has been 
an option for treating EPN. [140]  In a number of case studies later, patients have been 
successfully treated with a significant reduction in mortality rates in case of an early PCD in 
combination with medical management [129, 132]. PCD has also been found to be helpful in 
preserving the function of the affected kidney in about 70% of cases [127]. In patients who 
have been found to have localized areas of gas and in those with existing functioning renal 
tissue, early PCD should be performed. 
Since more than one catheter can be used to drain all, hence, loculations, abscess or multiple 
abscesses are not contraindications for PCD [127, 141]. The first target of the PCD should be 
the abscess that is technically accessible easier and could significantly reduce the pressure 
on the viable renal tissue. As there is a better success rate if compared with ultrasonography, 
ideally the insertion of a pigtail drain of at least 14 Fr should be guided under CT [134]. 
Unless follow-up CT shows resolution of the EPN features, the drainage tubes should stay 
in place, and if needed, flushed with antibiotic solutions. 
A gradual shift toward a nephron-sparing approach with early PCD has been noticed 
during the last decade with or without elective nephrectomy at a later stage. The various 
treatment strategies could be summarized as MM alone, early PCD plus MM, MM plus 
emergency nephrectomy, and PCD plus MM plus emergency nephrectomy [127] (Figure 2).  
Chen et al. have recommended follow-up CT in 4 to 7 days as beneficial to look for non-
communicating air/fluid collections in patients with early PCD plus MM [141]. This could 
also be found helpful in planning a nephrectomy for non-responders to PCD plus medical 
management.  
MM with PCD has found to be the most successful management method (30–100%) in two 
meta-analysis of the management strategies which has also been linked with the lowest 
mortality rate at 13.5% ( P 0.001) [127]. Nonetheless, subsequent nephrectomy could be 
required in a small proportion of patients managed with MM and PCD and the reported 
mortality stands at 6.6% that is significantly lower than medical management only approach 
(50%), or emergency nephrectomy (25%) alone (p _0.001) [127, 131]. 
MM alone or combined with PCD can lead to a good outcome in Class 1 and 2 EPN based 
on the Huang and Tseng classification. The survival rate with MM plus PCD is 85% in 
patients with fewer than two risk factors in Class 3 and 4 EPN, however, MM plus PCD was 
unsuccessful in 92% of cases in those patients with more than two risk factors. In 
comparison with the Class 1 and 2 EPN, the number of non-responders in this group who 
require nephrectomy is higher [130, 132].  
After PCD, the respective failure and mortality rates of 71% and 29% rate in Class 3A, and 
30% and 19% in Class 3B have  been described by Huang and Tseng [130].  
A meta-analysis has revealed that in patients who underwent an early PCD, elective 
nephrectomy is required only in 13% of them [127]. These patients either do not respond 
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well clinically to MM plus PCD, or on nuclear imaging they are found to have a 
nonfunctioning kidney. 
 
 
*Risk factors: diabetes, thrombocytopenia, acute renal failure, altered level of consciousness, shock. 
Fig. 2. EPN Management algorithm that is based on clinico-radiological classification by 
Huang & Tseng [130]. KUB, plain abdominal film of kidney, ureter and bladder. 
In these patients, nephrectomy can be either simple, or radical, or laparoscopic [124, 142]. 
The mortality rate could be as low as 10% if simple nephrectomy can be carried out [124, 
138]. Laparoscopic nephrectomy has been performed successfully in these patients with the 
advantage of a shortened recovery period and hospital stay [142].  
Renal support measures in the form of dialysis might be required in patients with EPN that 
it seems the availability of renal support reduces the mortality rate as concluded in a recent 
study [132].  
The best management strategy should be chosen based on an individualized case by case 
approach until prospective randomized studies come up with a definite conclusion. The 
degree and extent of parenchymal loss together with the coexisting renal disease determine 
the long-term outcome for renal function and the need for further support. 
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7. Xanthogranulomatous pyelonephritis  
7.1 Introduction 
In medical literature, xanthogranulomatous pyelonephritis (XPN) is described as a rare, 
severe, chronic renal infection typically resulting in diffuse renal destruction. There is a 
unilateral involvement in most cases that ends in a nonfunctioning, enlarged kidney 
associated with obstructive uropathy as a result of nephrolithiasis [143]. The most common 
pathology that is attributed to the disease is the simultaneous obstruction of the ipsilateral 
renal unit, most commonly due to an underlying stone disease with concomitant urinary 
tract infection [143]. In 1916, Schlagenhaufer presented the first descriptions of the 
distinctive gross and macroscopic features of XPN; however, the term xanthogranulomatous 
pyelonephritis was introduced by Oberling in 1935 [144]. 
The characteristic of xanthogranulomatous pyelonephritis is the renal parenchyma 
destruction and its replacement by a chronic inflammatory infiltrate and lipid-laden 
macrophages called xanthoma cells [145] that in turn results in an enlarged kidney that is 
either poorly functional or non-functional. 
Although the disease can be observed at any age, the majority of cases occur in middle-aged 
women. As it can affect the neonates, there is a possibility of prenatal origin as well [146]. 
XPN has been known to imitate virtually every other inflammatory disease of the kidney 
and on radiographic examination it is usually mistaken for renal cell carcinoma[147]. 
Moreover, because of the confusing microscopic similarities between xanthogranulomatous 
and clear cell adenocarcinoma of kidney on frozen section, it has ended in radical 
nephrectomy [145, 147, 148].  
7.2 Pathogenesis 
With regards to the pathogenesis, the primary factors involved in xanthogranulomatous 
pyelonephritis are nephrolithiasis, obstruction, and infection [149]. In up to 83% of the 
patients in various series, they have been found to have nephrolithiasis that staghorn type 
has comprised approximately one third to half of the renal stones [147, 150-152]. To a 
lower extent, there have also been reports of urinary tract obstruction as a result of UPJ 
obstruction, severe VUR and tumors (e.g. renal cell carcinoma, ureteral carcinoma, 
bladder carcinoma)[150, 153]. Also there is a greater risk of developing the disease in 
diabetics [154]. 
There has been a clinical and experimental postulation that primary obstruction with or 
without subsequent bacterial infection can lead to the tissue damage with the release of lipid 
material initiating the XPN. The lipid material is collected by macrophages. Then, these 
macrophages (xanthoma cells) are spread in sheets around parenchymal abscesses and 
calyces and are intermixed with lymphocytes, giant cells, and plasma cells. As spontaneous 
bacteriemia has been reported rarely, the bacteria seem to be of low virulence [143, 155].  
Venous occlusion and hemorrhage, abnormal lipid metabolism, lymphatic blockage, failure 
of antimicrobial therapy in UTI, altered immunologic competence, and renal ischemia are 
the other factors possibly interrelated [156, 157].  
The fact that XPN is treated successfully by nephrectomy, also the lack of other evidence for 
the systemic immune deficiency, has led to the assumption that immunological defect is 
unlikely. The reported malnutrition in these patients seems to be attributable to the effect of 
the XPN rather than its cause. Nonetheless, the cycle of events in the XPN pathogenesis is 
unclear [158]. 
www.intechopen.com
 Complicated Upper Urinary Tract Infection 75 
In the studies so far, no single factor has found to be instrumental in the pathogenesis of this 
disease. Instead, insufficient host acute inflammatory response within an obstructed, 
ischemic, or necrotic kidney seems to be the culprit. 
7.3 Pathology 
Grossly, kidney involvement in xanthogranulomatous pyelonephritis could be diffuse 
(80%), or segmental as well as surrounding tissues. 
The involved kidney is usually described as enlarged, with normal outline and the 
indication of nephrolithiasis, peripelvic fibrosis and dilated calyces filled with purulent 
material; however, the pelvis that is surrounded by fibrosis usually prevents pelvic dilation. 
Papillary necrosis leads to destruction of the papillae [143]. 
Typically, orange-yellow nodules of inflamed parenchymal tissue near the areas of tissue 
necrosis suppuration could be observed. Besides small localized abscess is a common 
finding. The renal cortex is thin and the xanthogranulomatous tissue usually replaces it. The 
renal capsule often thickens, and the inflammatory process expansion into the perinephric 
or paranephric space is common [143, 149, 156]. 
In microscopic examination, yellowish nodules that line the calyces and surround the 
parenchymal abscesses with dark sheets of lipid-laden macrophages or xanthoma cells 
(foamy histiocytes with small, dark nuclei and clear cytoplasm) could be noted (Figure 3). 
There is a mixture of the macrophages with a variety of inflammatory cells such as 
lymphocytes, plasma cells, neutrophils, and multinucleated giant cells. This seems necessary 
to mention that the presence of xanthogranulomatous cells is unspecific to 
xanthogranulomatous pyelonephritis and they may be found anywhere inflammation or 
obstruction exits [143, 156].  
 
 
Fig. 3. Xanthogranulomatous pyelonephritis. Prominent foamy histocyes admixed with 
mononuclear cells.( Courtesy of Simforoosh N., Sharifiaghdas F., Parvin M.,et al. The book 
“Urology Cases in Practice”. Labbafinejad Medical Center, Tehran, Iran.) 
7.4 Clinical presentation 
In patients with UTIs and a unilateral enlarged nonfunctioning or poorly functioning kidney 
with a stone or a mass lesion indistinguishable from malignant tumor, 
xanthogranulomatous pyelonephritis should be considered in the differential diagnosis. 
Since it has been termed “the great imitator” indicates the difficulty to characterize its 
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clinical and radiologic features. As a result, in most cases the precise diagnosis is made at 
the time of histopathology after nephrectomy. 
The disease presentation is nonspecific and its clinical demonstration varies markedly. The 
usual findings in most patients include flank pain, fever, and constitutional symptoms of 
fatigue, malaise, weight loss, and anorexia. Among those, a tender flank mass is the most 
common physical finding.  
In up to 50% of patients, there are abnormal liver function tests with occasional 
hepatomegaly. 
XGP inflammation could be extended into the perirenal or pararenal space, lymph nodes, 
ipsilateral Psoas muscle, colon, spleen, diaphragm, abdominal wall, and skin. This process is 
similar in pediatric patients and adults with similar clinical and pathologic findings. The 
classic triad is unilateral renal enlargement with little or no function and a large calculus in 
the renal pelvis without pelvic dilation in fifty to eighty percent of patients. A positive 
medical history for UTIs and urologic instrumentation could often be extracted. [152, 154, 
155, 158, 159]. 
Although xanthogranulomatous pyelonephritis with its unknown etiology can occur at any 
age; however, the peak age for its incidence is in the fifth to the seventh decade that 
predominantly affects women with no preference of involving either kidney [158]. 
7.5 Paraclinic findings 
In the literature review for the xanthogranulomatous pyelonephritis it can be realized that 
Proteus is the most common organism involved followed by E. coli [151, 158].The stone 
formation and subsequent chronic obstruction and irritation could be attributable to Proteus 
organisms [147]. Polymicrobial infections have found to be the responsible organisms in 
33% of a series of 36 cases that included some anaerobics. 
No microbial growth could be detected in the urine of one-third of the patients. It seems that 
the reason is either the preventive effect of the urinary tract obstruction not allowing the 
contaminated urine to reach the bladder, or it is because of the antibiotic treatment prior to 
the patient’s admission [151]. In some cases, only the cultures of the tissue obtained during 
the operation could reveal the organism. The common findings in urinalysis are pyuria and 
proteinuria; nonetheless, urine culture is sterile in 35 % of patients. Blood tests are usually 
indicative of anemia and leukocytosis that hepatic dysfunction could be found in as high as 
50% of the patients [159]. Azotemia or serious renal failure is uncommon due to the almost 
always unilateral involvement in xanthogranulomatous pyelonephritis [149]. 
In sonography, a global enlargement of the kidney is usually found. Instead of the normal 
renal parenchyma, many hypoechoic fluid-filled masses are detected that are debris-filled 
dilated calyces or foci of parenchymal destruction. In focal involvement, a solid mass is 
present in the involved segment of the kidney with an associated calculus in the collecting 
system or ureter. As to the differential diagnosis, renal cell carcinoma and other solid renal 
lesions must be considered [160]. 
A renal mass due to a localized renal enlargement could be presented. Less common 
findings in excretory urography are delayed function and possibly a massive 
hydronephrosis. Although smaller calcifications within the mass are not uncommon, 
however, they are not very specific. 
The point of obstruction could be shown by retrograde pyelography that it also reveals the 
dilation of the renal pelvis and calyces. In contrast studies, extensive parenchymal damage 
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could be demonstrated as an ulcerated pyelocalyceal system with multiple irregular filling 
defects. 
The most valuable radiologic means in evaluating patients with xanthogranulomatous 
pyelonephritis is probably CT scanning (Figure 4). By using this radiologic technique, an 
enlarged nonfunctioning kidney with decreased contrast enhancement, dilated calyces, and 
the evidence of obstruction often by a renal stone could be demonstrated [161, 162]. At 
times, a large reniform mass with the renal pelvis closely encircling a central calcification, 
but without pelvic dilatation, could be demonstrated [160, 163]. In the scans, multiple water-
density masses that are representative of dilated calyces and abscess cavities filled with 
varied amounts of pus and debris could be observed instead of normal renal parenchyma. 
On enhanced scans, however, the abundant vascularity within the granulation tissue could 
make the walls of these cavities demonstrate a prominent blush. In contrast to the tumors 
and other inflammatory lesions, the cavities themselves, do not enhance in the scans. 
 
 
Fig. 4. CT scan :a multifocal mass in left kidney(transverse view). ( Courtesy of Simforoosh 
N., Sharifiaghdas F., Parvin M.,et al. The book “Urology Cases in Practice”. Labbafinejad 
Medical Center, Tehran, Iran.) 
In properly evaluating the involvements of the perirenal and pararenal tissues, CT scan is 
very helpful that could reveal extension of the inflammatory process into structures nearby, 
or abdominal wall [154, 161]. 
In order to confirm and quantify the differential lack of function in the involved kidney, 
99mTc-DMSA radionuclide renal scanning is exploited [149]. 
MRI has not excelled CT in assessing renal inflammation yet, however, it has the advantage 
of outlining extra renal extension of inflammation. On T1 and T2-weighted images, lesions 
of xanthogranulomatous pyelonephritis could emerge as cystic foci of intermediate intensity 
and hyper intensity signal, respectively [164]. 
Xanthogranulomatous pyelonephritis and renal cell carcinoma cannot usually be 
differentiated in the radiologic studies despite the distinctive radiologic signs. The decisive 
diagnosis is usually made pathologically, mostly after nephrectomy. In the last decade, 
however, a combination of increasingly sensitive radiologic investigations and suspicious 
clinical signs has made the preoperative diagnosis possible. 
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7.6 Differential diagnosis 
In segmental xanthogranulomatous pyelonephritis with no calculus, the diagnosis may be 
difficult. In a small contracted kidney, the radiographic findings are nonspecific and non-
diagnostic for XPN [161, 163]. 
The usual differential diagnoses for xanthogranulomatous pyelonephritis are Wilms tumor, 
renal cell carcinoma, renal abscess, infected renal cystic disease, tuberculosis, malakoplakia, 
and transitional renal cell carcinoma. There have also been the reports of cases associated 
with renal carcinoma [148, 155]. 
Differentiation between xanthogranulomatous pyelonephritis presented with massive pelvic 
dilation and pyonephrosis is not possible. In renal parenchymal malacoplakia, there may be 
renal enlargement and multiple inflammatory masses instead of the normal renal 
parenchyma, however, calculi are usually absent. Renal lymphoma could be presented by 
multiple hypoechoic masses in the kidney enclosing the contracted, non-dilated pelvis. 
Nevertheless, the clinical signs for lymphoma are clear and calculi are absent and the renal 
involvement is usually bilateral [160]. 
7.7 Management  
The correct diagnosis is the first issue to tackle in the correct treatment of 
xanthogranulomatous pyelonephritis. XPN used to be diagnosed mostly postoperatively in 
the past [147]. With today’s accurate modern CT technology, diagnosis nears 90% 
preoperatively [152, 158].  
To stabilize the patient preoperatively, antimicrobial therapy is necessary that the renal 
function could be occasionally restored by eradicating the infection through long-term 
antimicrobial therapy[165].  
In a study by Tasi et al., an adult case was reported who had bilateral diffuse XPN with no 
fever and was successfully managed by supportive care without renal replacement therapy. 
The subsequent eighteen-month follow-up was proven to be uneventful with relatively 
stable renal function (serum creatinine 10.6 mg/dl). Therefore, it seems fever could be used 
as an indicator for nephrectomy [166]. Nonetheless due to the limited reported cases, the 
significance of pyrexia should be investigated further for its importance to be fully 
recognized. 
If the renal involvement is either diffuse or indistinguishable from a renal tumor 
preoperatively, nephrectomy is carried out. Nonetheless, for the localized 
xanthogranulomatous pyelonephritis, diagnosed preoperatively or at exploration, partial 
nephrectomy is preferred [147, 157]. 
To make the diagnosis solely on the basis of frozen section could be difficult as the lipid-
laden macrophages associated with xanthogranulomatous pyelonephritis are very similar to 
clear cell adenocarcinoma. There also seems to be relations between the cells in 
xanthogranulomatous pyelonephritis and renal cell carcinoma, papillary transitional cell 
carcinoma of the pelvis or bladder, and infiltrating squamous cell carcinoma of the pelvis 
[148, 157]. As a result, nephrectomy should be performed if malignant renal tumor cannot 
be ruled out. In case of an encounter with enlarged lymph nodes, the nodes should be 
dissected to exclude coexisting renal cell carcinoma[148]. 
If there is a diffuse and extensive disease that extends to the retroperitoneum, nephrectomy 
accompanied by the removal of the perinephric fat and the dissection of granulomatous 
tissue from the diaphragm, great vessels, and bowel may be required. 
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If nephrectomy is not performed and incision and drainage is carried out instead, the patient 
may continue suffering from a prolonged incapacitating illness that could advance toward 
cutaneous fistula and in such cases an even more difficult nephrectomy will then be 
necessary [147].  
Laparoscopic nephrectomy has been concluded as a reasonable approach to the treatment of 
xanthogranulomatous pyelonephritis in some literature reviews, but the fact is that most 
XPN cases were managed through open surgery and the conversion rate was high in those 
few cases that laparoscopic approach had been tried [159, 167]. 
8. Malacoplakia 
8.1 Introduction 
The Greek word “Malacoplakia” literally means soft plaque and the term is used for any 
unusual inflammatory disease that was originally described to affect the bladder, however, 
it has been found later that it could affect the genitourinary and gastrointestinal tracts, skin, 
lungs, bones, and mesenteric lymph nodes. Originally, this chronic inflammatory lesion was 
described by Michaelis and Gutmann in 1902. In 1903, it was characterized by von 
Hansemann as soft, yellow-brown plaques with  large polygonal shaped macrophages and 
foamy eosinophilic cytoplasm (von Hansemann cells) that the pathognomonic PAS-positive 
granules are called Michaelis-Gutmann bodies [168] 
Malacoplakia does not have exact known pathogenesis; however, it probably results from 
abnormal macrophage function against a bacterial infection, mostly E. coli.  
8.2 Pathogenesis 
Although the true pathogenesis is unknown, but there are several popular theories 
available. Of some 93 patients who had cultures of urine, diseased tissue, or blood, 89.4% 
were found to have coliform infections [168]. Of the total number of patients in this review, 
some 40% of the patients had an immunodeficiency syndrome, autoimmune disease, 
carcinoma, or another systemic disorder. In malacoplakia, this association of coliform 
infections and patients’ compromised health status is well recognized. 
The distinguishable Michaelis-Gutmann bodies are believed  to originate from the 
phagolysosomes containing incompletely destroyed bacteria with abnormal deposition of 
calcium and iron [168]. As many authors agree there is a decreased intra cellular 
cGMP/cAMP ratio that seems to diminish capacity of macrophages for bacterial lysis. 
Hence, in Malacoplakia the assumption exists that the underlying cellular defect is the 
impaired intracellular killing of bacteria [169, 170]. The most frequent bacteria associated 
with malacoplakia are coliforms that in 75% of cases is E. coli [169]. 
8.3 Pathology 
To diagnose the disease, biopsy should be carried out that the lesion has the characteristic 
large histiocytes, known as von Hansemann cells, and pathognomonic small basophilic, 
extracytoplasmic, or intracytoplasmic calculospherules called Michaelis-Gutmann bodies.  
Electron microscopy has been able to demonstrate the intact coliform bacteria and bacterial 
fragments within phagolysosomes of the foamy-appearing malacoplakic histiocytes [168]. It 
has been emphasized that Michaelis-Gutmann bodies though pathognomonic for the 
disease, may not be observed in early malacoplakia; hence, they are not necessary for the 
diagnosis [168, 171]. 
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Large amounts of immunoreactive α1-antitrypsin have been detected in macrophages in 
malacoplakia involving the kidney and bladder [172]. In other pathologic processes that 
macrophages closely look alike the ones in malacoplakia, but without Michaelis-Gutmann 
bodies, they do not contain α1-antitrypsin that is with the exception for a few macrophages 
in tuberculosis and xanthogranulomatous pyelonephritis. In malacoplakia, hence, α1-
antitrypsin immunohistochemical staining could be a useful test for an early and accurate 
differential diagnosis.  
8.4 Clinical presentation 
The majority of patients are females who are over the age of 50 with a recurrent urinary tract 
infection history. For the malacoplakia in the urinary tract, the female to male ratio is 4:1; 
however, this ratio does not stand for other body tissues [168, 169]. The affected patients 
who are mostly debilitated, are immunosuppressed, with  other chronic diseases and they 
are similar to those patients on long-term steroid administration and individuals with 
acquired immunodeficiency syndrome, lymphoma, and diabetes mellitus [168]. 
Malacoplakia could appear through various clinical presentations that is appropriate to the 
location of the disease-associated plaques and can involve any portion of the urinary tract, 
nonetheless, the bladder is the most commonly involved site and it is followed by the renal 
parenchyma, ureters, and renal pelvis [168, 169]. 
The symptoms for the bladder malacoplakia that is more common than the other types of 
urinary tract involvement are bladder irritability and hematuria. In cystoscopy, mucosal 
plaques or nodules could be detected. With the progress of these lesions, they may become 
fungating, firm, sessile masses that result in filling defects of the bladder, ureter, or pelvis on 
excretory urograms. The disease process may cause distal ureter to be strictured or stenotic 
with subsequent renal obstruction or nonfunction [173].  
In malacoplakia, the common renal parenchymal disease may be presented with flank pain 
or tenderness, palpable mass, pyuria, hematuria, and fever [173] accompanied by the history 
of urinary tract infections. Due to the usual enlargement of the affected kidney, it  is 
commonly misdiagnosed as renal abscesses or malignant growths, particularly if there is 
concomitant lung involvement that can mimic metastatic disease [174]. In rare cases, 
malacoplakia has been reported as bilateral hydronephrosis and ureteral involvement [173, 
175]. It can also cause renal vein thrombosis, inferior vena cava thrombosis, or progressive 
renal failure. Malacoplakia should be considered in the differential diagnosis of acute renal 
failure if it directly involves the renal parenchyma, also in those rare cases of bilateral renal 
disease that the end-stage renal failure has been resulted [173, 176]. 
The renal malacoplakia may extend beyond the kidney and it may also be potentially fatal 
due to post-infectious glomerulonephritis secondary to bacterial presence in the renal 
parenchyma, and unlike bladder involvements, is a progressive and destructive 
parenchymal disease [177, 178]. 
With the advancement of the medical science, renal parenchymal disease is no longer 
considered as a frequently fatal disease in the new millennium; however, the morbidity rate 
still remains high and progress toward renal failure will ensue in a considerable number of 
patients with time [176]. 
8.5 Paraclinic findings 
Urine cytology: It could possibly reveal the presence of cells with Michaelis- Gutmann bodies 
in the urine sample tested [179].  
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Depending on the degree of internal necrosis, ultrasonography and CT may demonstrate a 
solid or cystic structure. Ultrasonography, CT, and arteriography are helpful means to 
establish the multifocal nature. 
The most common sonographic finding in renal parenchymal malacoplakia is diffuse 
enlargement of the affected kidneys, and to a lower extent, hypoechoic lesions, distortion of 
parenchymal echoes, and increased echogenicity of the parenchyma could be observed too 
[180, 181].  
The most common CT findings include nephromegaly and parenchymal inhomogeneity. 
The density of the foci of malacoplakia is less than the surrounding enhanced parenchyma. 
Nevertheless, there have been images available mimicking malignant renal infiltration 
presenting by masses with increased focal uptake, heterogenecity of focal necrosis, abscesses 
and multiple retroperitoneal lymph node of significant size with hypodense necrotic center 
[179, 182]. CT has also the best capability to demonstrate the extension beyond the kidney 
occurring either in multifocal or uniform malacoplakia [182]. 
The typical presentation of the multifocal malacoplakia on excretory urography is enlarged 
kidneys with multiple filling defects and it is on the contrary to the unifocal lesion that 
appears as a non-calcified mass indistinguishable from other inflammatory or neoplastic 
lesions. Moreover, renal calcification, lithiasis, and hydronephrosis do not exist [183].  
In a typical arteriography, a hypovascular mass without peripheral neovascularity could be 
observed [183]. 
8.6 Differential diagnosis 
Histopathologic analysis could establish the diagnosis; yet the diagnostic value of the 
cytologic analysis of fine-needle aspirates has also been demonstrated. Since malacoplakia 
has no characteristic clinical or radiologic sign, thus, biopsy is crucial both to confirm the 
diagnosis and to help exclude other possible pathologies [184]. 
In case of observing one or more renal masses, malacoplakia should be suspected, 
particularly in females with recurrent UTIs with E. coli, altered immune response 
syndromes, or cystoscopic evidence of malacoplakia or filling defects in the collecting 
system. In a renal transplant patient with these radiographic findings and persistent UTI 
who has received appropriate antimicrobial therapy, malacoplakia should also be suspected.  
The differential diagnoses to consider are renal cystic disease, neoplasia, and renal 
inflammatory disease [184]. To exclude cystic disease in general, careful sonographic and CT 
evaluations could be carried out. In the course of the disease, late renal involvement with 
metastatic disease or lymphomas usually occurs that is well documented. Most often, 
multifocal renal cell carcinoma is seen in the context of von Hippel-Lindau disease together 
with its other clinical manifestations. Similar to malacoplakia, signs and symptoms of UTI 
are usually available in the patients with xanthogranulomatous pyelonephritis and the 
involved kidney is enlarged; however, renal calculi and obstruction are common. Multiple 
renal abscesses are often the result of hematogenous dissemination originated by cardiac 
disease. 
8.7 Management 
To stabilize the disease process and to manage malacoplakia, the control of the UTIs should 
be the target of the treatment [168]. 
An antibiotic with an excellent cell membrane penetration is the cornerstone of treatment 
that fluoroquinolones are effective in up to 80 -90% of cases and since their debut in the 
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early 90’s, they have been the greatest support in the literature to manage the disease [176, 
185]. They have been the first choice of treatment due to the easy passage through the 
macrophage and histiocyte cell wall providing high concentrations there [179, 186]. 
Despite the use of various long-term antimicrobial agents such as many antituberculosis 
agents, however, the sulfonamides, rifampin, doxycycline, and TMP are found to be 
particularly useful owing to their intracellular bactericidal activity [179, 185]. 
In the patients that receive immunosuppressive therapy for any reason, the suspension of 
their medications is advisable during the treatment period. 
As phagocytic dysfunction is supposedly the reason behind the malacoplakia, the use of 
ascorbic acid (Vitamin C) and cholinergic agents such as bethanechol in conjunction with 
antimicrobial therapy have been reported with good results in the restoration of phagocytic 
function [168, 179]. It is believed that the aforesaid agents work through increasing 
intracellular cyclic guanosine monophosphate levels (cGMP) that its biologic defect 
seemingly leads to macrophage dysfunction and its availability restores lysosomal function 
that in turn enhances phagocytosis. 
If the disease progresses in spite of antimicrobial treatment, surgical intervention could be 
indicated that for the treatment of symptomatic unilateral renal lesions, nephrectomy is 
usually performed. As to the often very aggressive nature of the retroperitoneal 
involvement, it could be fatal [176, 179]. 
Prognosis seems appropriate to the extent of the disease in the long-term. In bilateral 
parenchymal renal malacoplakia or in the transplanted kidney the survival is usually 
limited to 6 months [179, 186]. On the opposite, the long-term survival after nephrectomy in 
the unilateral disease is good that in a literature review in 2003, the survival rate was found 
to be over 90% in such patients. Nonetheless due to the possible long-term relapse, these 
patients must always undergo close evaluation periodically [176].  
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